Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations

Volume 17, Issue 1, January 2016, pages 65-78<br/>10.1080/15384047.2015.1108492<br/>Do-Hee Kim

from Cancer via ola Kala on Inoreader http://ift.tt/1ofOroK
via IFTTT